New antibiotics against DNA. Topoisomerase I of S. pneumoniae

Thumbnail Image

Download

New_antibiotics_Poster_2010BIOSPAIN.pdf (1.22 MB)

Official URL

Full text at PDC

Publication date

2010

Authors

Advisors (or tutors)

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Citations
Google Scholar
Exportar
DC QDC MarcXML RDF MODS METS ORE-ATOM

URI

https://hdl.handle.net/20.500.14352/130565

Citation

Abstract

S. pneumoniae is the main ethological agent of community-acquired pneumonia. Pneumococcal DNA topoisomerase complement, that control its DNA topology, consists of two type II enzymes (DNA gyrase and DNA topoisomerase IV) and a single type I enzyme (DNA topoisomerase I, TopA). While fluoroquinolone antibiotics target the type II topoisomerases, no antibiotics against TopA has yet been reported. Antibiotic resistance is a serious clinical problem in all the world. An increase in resistance to fluoroquinolones in S. pneumoniae it is not unexpected. Therefore, it is necessary to look for new antibiotics against new targets

Research Projects

Organizational Units

Journal Issue

Description

UCM subjects

Microbiología médica, Biología molecular (Biología), Farmacología (Medicina)

Unesco subjects

3201.03 Microbiología Clínica, 2302.21 Biología Molecular, 2302.22 Farmacología Molecular

Keywords

Collections

Ponencias o Pósters de Seminarios, Congresos, etc